光一科技(300356.SZ):持股5%以上股東乾瀚投資減持84.02萬股 減持計劃實施完成
格隆匯 9 月 29日丨光一科技(300356.SZ)公佈,公司於2020年3月9日披露了《關於持股5%以上股東減持股份的預披露公告》(公告編號2020-007),股東湖北乾瀚投資有限公司(下稱“乾瀚投資”)計劃自減持計劃披露之日起15個交易日後的六個月內,以集中競價方式減持公司股份不超過822萬股(約佔公司總股本的2%),在連續90個自然日內減持股份總數不超過總股本的1%,減持價格參照市場價格。
截至本公告日,上述減持計劃的期限即將屆滿,乾瀚投資減持股數84.02萬股,減持比例0.20%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.